Tekcapital Share Discussion Threads

[iamgreat1] 23/3/2020 14:58

Massive spread as wellRns confirms there is a seller who have over 5% holding any buying will be sold into

[smithie6] 23/3/2020 13:26

can you justify your comment

"So a great innovation which is highly likely to get material coverage with end buyers in far greater numbers and speed of demand than normally would have been."

noting that they have applied for a patent

ie. they have given 2 copies of some papers with text & diagrams to a national office.

The income from doing that was zero.
The number of units available for delivery today as a result of submitting those papers was....0.

correct me if I am wrong but the item that is 'patent pending' is NOT even in production & wont be for X weeks/months

(& the patent application does not include production drawings, only general sketches)

----

Im still of the opinion that the spike as a result of Belluscura is over today

[superg1] 23/3/2020 12:38

Herd

Because Iam is trying to trade it sold and wants back lower.

The M/C seems very good value based on the Belluscura tech. As said before the junk posters arrived a decent debate happened some months back.

Just about all not interested in anything other than the salt side with the Belluscura part being the main attraction.

Transformational re COPD sufferers but obviously now the issue with viruses and breathing difficulties is much more prominent that it normally would be.

So a great innovation which is highly likely to get material coverage with end buyers in far greater numbers and speed of demand than normally would have been.

[iamgreat1] 23/3/2020 11:39

Edale dumping they have a lot of shares Expect this to fall back

[superg1] 23/3/2020 11:27

So it's highly likely the Belluscura kit will get the FDA approval in quick time, IE imminently.

Surely under the circs Belluscura will bring forward their launch timetable and in theory they are likely to see considerable demand.

As they have the launch this year, then no doubt they already have manufacturers lined up.

Not so much about the demand but the brand\innovation recognition for the long term in quick time.

[smithie6] 23/3/2020 11:15

ventilation for humans.

Belluscura (Tek has ~20% I think) has applied for a patent

but does any fixed hospital ward Belluscura product have medical authorisation ?

is any Bell. product for fixed hospital ward product in volume production today ??

(a paper patent has no value imo for the current Covid19 crisis imo

hospitals need ventilators this week !!
in 3 months hopefully no one will be buying ventilators
& cos. are stepping up to try to provide them. & one assumes that most of that will be achieved by increasing production of existing units


(going into production with a new design takes time...
for moulded plastic parts then a mould(s) needs to be made in metal,
& for many/most pressed metal parts again a mould needs to be designed & built

production/fitting problems have to be fixed, moulds altered or changed etc etc

& then say 10 prototype units have to be tested & authorised (quicker in current crisis but needs to happen)

the website shows that the co. is mostly interested in mobile units, imo

which is a different use than in a hospital ward.

the website shows products for providing air with high oxygen content
imho that is not what the hospitals are shouting that they need "now" !

hospitals have oxygen in tubes around the walls...& they can connect it easily & put a mask on a patient's face; imo the Tek related product seems to have no use in such a hospital ward (while it might be useful in a care tent erected outside the hospital doors; but oxygen tanks exist to serve that need)

---

so Im skeptical

anyone want to convince me that Im misguided ?

[stocktrend2] 23/3/2020 09:59

Remembee to bank profits next multi bagger is lvcg check this out

www.voxmarkets.co.uk/articles/live-company-group-and-russ-mould-on-bear-markets-22f5e04

[philjeans] 23/3/2020 09:48

TEK were 50p three years ago - miles to go here with Bellescura and Micro-Salt.

[philjeans] 23/3/2020 09:46

lol - he's never been in TEK!

Good luck with SNG - all over there mate - way overpriced now and profit takers all over it.!

TEK has several excellent investee co's and has hardly started!

BUY

[jayminpatel1] 23/3/2020 09:28

Out now all profits back into SNG

[tomboyb] 23/3/2020 09:06

84% -

The overhang looks done -

[philjeans] 23/3/2020 09:03

16 March 2020
Tekcapital plc
("Tekcapital" or the "Company")
Portfolio Company Update
Belluscura plc announced the filing of a patent application on a modular,
portable oxygen enrichment ventilation system
Tekcapital plc, (AIM: TEK) the UK intellectual property investment group focused on creating marketplace value from investing in university technology, announces that its portfolio company Belluscura plc in conjunction with its exclusive research partner Separation Design Group, announced today the filing of a patent application covering novel modular portable oxygen enrichment ventilation systems for treating patients suffering from chronic obstructive pulmonary diseases (COPD) and acute respiratory distress syndrome (ARDS) brought on by such diseases as COVID-19.
This latest patent application covers devices and systems for treating people suffering from COPD and ARDS including patients suffering from the recent coronavirus, COVID-19. The primary cause of death from respiratory viruses like the coronavirus and influenza, are the result of the fluids accumulating inside the alveoli (the tiny air sacs of the lungs) which ultimately leads to the failure of the transfer of oxygen to and carbon dioxide out of the blood. The current primary treatment for ARDS is oxygen therapy along with ventilator support.
Belluscura and Separation Design are rapidly designing and developing next generation, cost-effective, portable oxygen enrichment and ventilation technology to treat COPD and ARDS patients.
Commenting on the patenting activities, Bob Rauker, CEO of Belluscura, said: "We are very excited about our next generation oxygen technologies. With the launch this year of our first product, the X-PLOR(TM) portable oxygen concentrator, into the respiratory treatment field where over 250 million people suffer from chronic obstructive pulmonary disease (COPD), the third leading cause of death, it is critical that we continue to innovate into the ever-expanding oxygen therapy market". Doug Galbraith, CEO of Separation Design, lead inventor on over 12 oxygen enrichment patents, states, "We need to continue developing cost-effective respiratory solutions to meet the healthcare demands of the future."
About Belluscura plc

[philjeans] 23/3/2020 08:51

Bargain here !

[hope67] 23/3/2020 08:48

Greta news that this is a multibagger in the making

[timberwolf3] 23/3/2020 08:47

Here's the FDA download

[timberwolf3] 23/3/2020 08:46

Good news, no wonder the share price is reacting.

[hope67] 20/3/2020 10:52

watch this

[hope67] 20/3/2020 09:06

hxxps://komonews.com/news/coronavirus/bothell-company-increasing-production-of-ventilators-in-response-to-covid-19

[tomboyb] 20/3/2020 08:50

This latest patent application covers devices and systems for treating people suffering from COPD and ARDS including patients suffering from the recent coronavirus, COVID-19. The primary cause of death from respiratory viruses like the coronavirus and influenza, are the result of the fluids accumulating inside the alveoli (the tiny air sacs of the lungs) which ultimately leads to the failure of the transfer of oxygen to and carbon dioxide out of the blood. The current primary treatment for ARDS is oxygen therapy along with ventilator support. -

Any stock which deals with respiratory illnesses will get a mention -

[tomboyb] 20/3/2020 08:43

There will be a lot more interest in COPD diseases -

Lets see -